In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
For many of the nation's mutual fund boards, it's 15(c) season. In the current environment, that means independent directors and counsel are grappling with completing the ...
For all of us, video meetings are the new normal, and at least for now few directors yearn to return to the days of traveling to ...
Now that summer is officially here, folks are beginning to look forward to the fall and wondering when (or if) things will go back to some ...
Mutual fund boards can continue conducting business—including voting on contract approvals and renewals and other important matters—virtually through the end of 2020, according to the Securities ...